NUDT1 and cancer: Furthermore, inhibition of MTH1 in combination with cellular antioxidant defense might be suited for targeting phenotypic heterogeneity of cancer cells caused by adaptation to chronic-cycling hypoxia in hypoxic tumor fractions.